[In vivo T-lymphocyte activation in patients with multiple sclerosis].
Patients with multiple sclerosis present changes in lymphocyte subtypes in the peripheral blood. In this study, the authors demonstrate that patients with clinical activity or under an episode show marked increases in the percentages of activate lymphocytes detected through monoclonal antibodies against transferrin and interleukin 2 receptors.
Tilbery
C P
CP
Atra
M
M
Scheinberg
M A
MA
D000911:Antibodies, Monoclonal; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology*; D009103:Multiple Sclerosis / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000032:analysis; D011990:Receptors, Transferrin / Q000032:analysis; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D015375:Receptors, Interleukin-2; D011990:Receptors, Transferrin
Ativação "in vivo" de linfócitos T em pacientes com esclerose múltipla.